Advancing immunotherapies
with avidity intelligence
Most immunotherapies fail because the best candidate was never found.
We help you uncover it faster, with greater biological confidence.
Most immunotherapies fail because the best candidate was never found.
We help you uncover it faster, with greater biological confidence.
Most immunotherapies fail because the best candidate was never found.
We help you uncover it faster, with greater biological confidence.
Most immunotherapies fail because the best candidate was never found.
We help you uncover it faster, with greater biological confidence.
Most immunotherapies fail because the best candidate was never found. We help you uncover it faster, with greater biological confidence.
Captures the full complexity of live immune–target cell interactions, delivering insights that better reflect in-vivo therapeutic behaviour.
Analyses tens of thousands of single-cell interactions per run—and scales to millions, enabling comprehensive profiling of diverse immune cell populations.
Maintains cell viability and functionality for immediate downstream testing, seamlessly integrating into your existing R&D pipeline.
Compatible with a wide range of adherent target cells and immune cell types, including TCR-T, CAR-T, NK, and beyond—across various solid tumour indications.
Captures the full complexity of live immune–target cell interactions, delivering insights that better reflect in-vivo therapeutic behaviour.
Analyses tens of thousands of single-cell interactions per run—and scales to millions, enabling comprehensive profiling of diverse immune cell populations.
Maintains cell viability and functionality for immediate downstream testing, seamlessly integrating into your existing R&D pipeline.
Compatible with a wide range of adherent target cells and immune cell types, including TCR-T, CAR-T, NK, and beyond—across various solid tumour indications.
Avigen was highly professional and a pleasure to work with, delivering high-quality data on a rapid timeline. Their avidity-based analysis provided valuable insight beyond standard assays and provided a new layer of validation data for future decision-making.
Avigen approached our project with strong attention to detail and scientific integrity. Their careful optimisation of difficult assay conditions ensured in reliable, robust data that we could trust. The avidity readouts holistically captured meaningful aspects of functional immune–target engagement that was previously difficult to evaluate, adding a new layer of validation to our preclinical R&D. Interactions with the team were consistently positive and enjoyable. I would strongly recommend the team and their platform.








Avigen was highly professional and a pleasure to work with, delivering high-quality data on a rapid timeline. Their avidity-based analysis provided valuable insight beyond standard assays and provided a new layer of validation data for future decision-making.
Avigen approached our project with strong attention to detail and scientific integrity. Their careful optimisation of difficult assay conditions ensured in reliable, robust data that we could trust. The avidity readouts holistically captured meaningful aspects of functional immune–target engagement that was previously difficult to evaluate, adding a new layer of validation to our preclinical R&D. Interactions with the team were consistently positive and enjoyable. I would strongly recommend the team and their platform.
Avigen was highly professional and a pleasure to work with, delivering high-quality data on a rapid timeline. Their avidity-based analysis provided valuable insight beyond standard assays and provided a new layer of validation data for future decision-making.
Avigen approached our project with strong attention to detail and scientific integrity. Their careful optimisation of difficult assay conditions ensured in reliable, robust data that we could trust. The avidity readouts holistically captured meaningful aspects of functional immune–target engagement that was previously difficult to evaluate, adding a new layer of validation to our preclinical R&D. Interactions with the team were consistently positive and enjoyable. I would strongly recommend the team and their platform.
